Colorectal neoplasia results from a progressive process of gene mutation and epigenetic alterations that drive the initiation and progression of normal colon to benign adenomas to malignant adenocarcinomas (paralleling histological changes) because these mutations affect signaling pathways that deregulate hallmark behaviors of normal colon stem cells. DNA mismatch repair (MMR), an evolutionary-conserved system that repairs polymerase mistakes after DNA synthesis and corrects insertion/deletion (I/D) loops at microsatellite sequences throughout the genome, is disrupted in the germline of familial colon cancer (Lynch syndrome) as well as inactivated in up to 20% of sporadic colorectal neoplasms due to hypermethylation of one of the components of DNA MMR. The genetic consequences of disrupted DNA MMR is non-repair of the polymerase mistakes and insertion/deletion loops that occur in non-coding as well as coding microsatellite regions after DNA heteroduplexes form first, causing neoplasia to commence that defines the clinical syndromes. We hypothesize that human DNA MMR has specific recognition fidelity in targeting repair of I/D loops, but the fundamentals of how heteroduplex DNA forms are independent of DNA MMR. Our preliminary data using novel constructs in which to measure human DNA MMR mutation indicate that (a) heteroduplex DNA forms prior to mutation and appears independent of the DNA MMR status, and that full mutation is only seen with defective DNA MMR, and (b) the ability of microsatellites to form I/D loops and subsequent mutation is influenced by flanking DNA sequences that surround the microsatellite. Additionally, there is growing evidence that elevated microsatellite instability at selected tetranucleotide repeats (EMAST), seen is 60% of colon cancer specimens, may be associated inflammation-induced reduction of the DNA MMR protein hMSH3, causing this genetic signature. How EMAST fits into the pathogenesis of colon neoplasia is not defined. In this continuation proposal, we will focus on hMSH3 and how deficiency causes EMAST, and determine the biological consequences of EMAST. More specifically, we hypothesize that hMSH3 prevents tetranucleotide frameshifts, and this will be examined in Specific Aim 1. We further aim to understand the role of hMSH3 on influencing potential target genes for mutation (Specific Aim 2). We will also define EMAST by hMSH3 expression, and examine the link of inflammation with hMSH3 and EMAST (Specific Aim 3). The impact of this proposal lies in understanding the fundamentals of how DNA is altered to drive a common cancer, and our ability to potentially intervene ultimately by pharmacologic or direct intervention to prevent occurrence or death from colorectal cancer.

Public Health Relevance

Colorectal cancer is among the most common cancers afflicting Americans. This cancer is derived and driven by conditions, some within DNA, that allow for mutation of key growth regulatory genes that then abrogates their normal regulatory function. This proposal aims to understand how DNA becomes mutated, as well how inflammation may influence this mutation. Ultimately, interfering with this process through pharmacologic or direct intervention should prevent or reduce colorectal cancer deaths.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Clinical, Integrative and Molecular Gastroenterology Study Section (CIMG)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Internal Medicine/Medicine
Schools of Medicine
Ann Arbor
United States
Zip Code
Tseng-Rogenski, Stephanie S; Hamaya, Yasushi; Choi, Daniel Y et al. (2015) Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells. Gastroenterology 148:579-89
Carethers, John M (2014) DNA testing and molecular screening for colon cancer. Clin Gastroenterol Hepatol 12:377-81
Carethers, John M; Murali, Bhavya; Yang, Bing et al. (2014) Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One 9:e100461
Carethers, John M (2014) Differentiating Lynch-like from Lynch syndrome. Gastroenterology 146:602-4
Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Carethers, John M (2013) Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity. Mutat Res 747-748:19-27
Lee, Sun-Young; Miyai, Katsuya; Han, Hye Seung et al. (2012) Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia. Dig Dis Sci 57:72-8
Chung, Heekyung; Chaudhry, Joy; Lai, Jenny F et al. (2012) Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2). Mutat Res 729:73-80
Huang, Sherry C; Lee, Jeffrey K; Smith, E Julieta et al. (2011) Evidence for an hMSH3 defect in familial hamartomatous polyps. Cancer 117:492-500
Tajima, Akihiro; Iwaizumi, Moriya; Tseng-Rogenski, Stephanie et al. (2011) Both hMutSýý and hMutSýý DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity. PLoS One 6:e28117
Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Carethers, John M (2011) DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells. Cancer Biol Ther 12:756-64

Showing the most recent 10 out of 37 publications